Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Industries

50 Biotech US IPOs in 2013 - Offer encouragement for India’s biotech industry


Print article Print article
2013-12-27 13:02:57 - In 2013, 50 US IPO's in biotech has received huge offerings. BIOINVEST 2014 on 24th January in Mumbai aims to bring investors together to explore the opportunities in the biotechnology sector.

Mumbai, December 27, 2013: This year the Biotech sector in the US saw a record offering of over 50 IPOs that raised approx. 7.5 billion USD. The numbers were impressive by any standards and should give companies in the sector ample reason to cheer. But the fact remains that most of the action happened in the US, with a few IPOs in Israel.

The Indian Biotechnology industry has been growing at a healthy clip and accelerating towards the anticipated 100 billion USD by 2025. That would ofcourse need a growth rate of 30 -35% which seems to be difficult task at a time when there are a quite a few fundamental issues, both at the macro and micro level. Investment trends

in India seem to indicate that the optimism of the US firms has not made much of a difference to the Indian investment scenario in the short term. But will it in the medium to long-term remains to be seen.

Biotech leaders in India will meet during ‘BIOINVEST 2014’ ableindia.in/bioinvest2014/ in Mumbai on January 24, 2014 to bring together on one platform Life science companies, Institutional Investors and Investment bankers to explore opportunities for investment in biotechnology sector for the next 5 years. Some visible trends including Big Data and Manufacturing particularly biologics may offer solutions for the growth of the sector. The conference will also deep dive into skill development and education as the main pillars for the industry to grow.

The recent announcement of a 1 billion USD investment by a Pharma MNC is definitely encouraging and goes to prove that India remains an attractive investment destination despite challenges. In the past year a significant investment in the drug discovery space by a Japanese major also bodes well for India’s capabilities.

As per Dr. PM Murali, President, ABLE, “The Indian biotech sector holds the potential to address various challenges including healthcare, agriculture and pharma and BIOINVEST conference aims at finding the right path of growth for the sector by bringing together the industry to debate and discuss on the potential offered by the biotech sector. Also, the new Environment Minister Mr. Veerappa Moily is now considering approval for GM crops. This is a very good sign for attracting investment into the agriculture sector.”

About ABLE

Association of Biotechnology Led Enterprises - ABLE is a not-for-profit pan-India forum that represents the Indian Biotechnology Sector. It was launched in April 2003, after industry leaders felt a need to form an exclusive forum to represent the Indian Biotechnology Sector. It has over 270 members from all across India representing all verticals of the sector like agribiotech, bio-pharma, industrial biotech, bioinformatics, investment banks and Venture Capital firms, leading research and academic institutes and law firms and equipment suppliers. The primary focus of ABLE is to accelerate the pace of growth of the Biotechnology sector in India, through partnering with the Government in their biotechnology initiatives to deliver optimal policies and create a positive regulatory environment, encouraging entrepreneurship and investment in the sector, providing a platform for domestic and overseas companies to explore collaboration and partnerships, forging stronger links between academia and industry and showcasing the strengths of the Indian biotech sector. In the past decade ABLE has played a significant role in catalyzing the growth of the biotech industry by facilitating advocacy, collaboration, investment and encouraging entrepreneurship. Some of the milestones that ABLE has achieved are those related to Dr.Mashelkar Committee report on recombinant product, Innovative programs of the DST viz. BIRAP and BIPP , Vision document for the Indian Biotech industry, Roadmap for the biotech Industry, building the Biotechnology Entrepreneurship Students team (BEST) and North East Life Science Entrepreneurship (NEST) programs, the BioInvest Program and the International promotion of Brand India through organizing the India Pavilion in various BIO Shows - www.ableindia.in


Contact Information:
Association of Biotechnology Led Enterprises



Contact Person:
Anjana Kovoor
PR Consultant
email: email




Author:
Gopal Kommuri
e-mail
Web: www.the-practice.net
Phone: 9379441317

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com